Log In
Print
BCIQ
Print
Print this Print this
 

Oral Recosulin (Generex Oral-lyn)

Also known as: Oral-lyn, insulin (Oralgen, Oralin)

  Manage Alerts
Collapse Summary General Information
Company Generex Biotechnology Corp.
DescriptionBuccal spray insulin delivered via RapidMist technology
Molecular Target Insulin receptor (INSR)
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentApproved
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat impaired glucose tolerance associated with pre-diabetes; Treat postprandial hyperglycemia; Treat Type I and Type II diabetes; Treat Type I diabetes; Treat Type II diabetes
Regulatory Designation

Partner

Dong Sung Pharmaceutical Co. Ltd.; Shreya Life Sciences Pvt. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today